Patents Assigned to GOLDCREST MEDICINE INSTITUTE CO., LTD.
  • Publication number: 20170112741
    Abstract: To provide a novel agent for ameliorating a skin symptom such as pigmented macules or ephelides, a novel hair growth agent, and a novel slimming agent. The agent for ameliorating a skin symptom, the hair growth agent, or the slimming agent contains a dopamine agonist as an active ingredient, in which the skin symptom is selected from pigmented macules, periorbital dark circles, darkish skin, black darkish skin, moles, ephelides, birth marks, and seborrheic keratosis.
    Type: Application
    Filed: April 8, 2015
    Publication date: April 27, 2017
    Applicant: GOLDCREST MEDICINE INSTITUTE CO., LTD.
    Inventor: Kazuo TORII